论文部分内容阅读
目的评价宫颈癌血管性介入治疗在同步放化疗中的价值。方法将41例ⅡB期、30例ⅢB期宫颈癌患者随机分为动脉化疗组和化疗栓塞组进行治疗观察。结果临床缓解率达100%。ⅡB期宫颈癌患者的5年总生存率为73.2%,ⅢB期为60%。化疗栓塞组生存率高于单纯化疗组,但无统计学差异(P>0.05)。结论宫颈癌血管性介入治疗起效快,疗效好,是同步放化疗的一项重要内容。
Objective To evaluate the value of vascular interventional therapy in concurrent chemoradiotherapy for cervical cancer. Methods 41 patients with stage ⅡB and 30 stage ⅢB cervical cancer were randomly divided into arterial chemotherapy group and chemoembolization group. Results The clinical remission rate was 100%. The 5-year overall survival was 73.2% in patients with stage IIB cervical cancer and 60% in stage IIB. The survival rate of chemotherapy and embolization group was higher than that of chemotherapy group, but there was no significant difference (P> 0.05). Conclusion The vascular interventional therapy of cervical cancer has rapid onset and good curative effect, which is an important content of concurrent chemoradiotherapy.